We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics- Hematology Division

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

New Highly Sensitive Blood Test Accurately Measures Immunity Against SARS-CoV-2

By LabMedica International staff writers
Posted on 16 Jul 2021
Print article
Image: New Highly Sensitive Blood Test Accurately Measures Immunity against SARS-CoV-2 (Photo courtesy of EPFL / Alain Herzog 2021)
Image: New Highly Sensitive Blood Test Accurately Measures Immunity against SARS-CoV-2 (Photo courtesy of EPFL / Alain Herzog 2021)
A team of researchers have developed a new test that is sensitive enough to measure the amount of SARS-CoV-2 neutralizing antibodies present in the bloodstream.

The discovery by scientists at the Lausanne University Hospital (CHUV; Lausanne, Switzerland) and EPFL (École polytechnique fédérale de Lausanne; Switzerland) opens up promising new avenues for tracking immunity acquired by infection or vaccination. With this test, experts can measure the level of protection against variants of the virus and monitor their prevalence over time.

Blood tests detect the presence of antibodies against an infectious agent, such as SARS-CoV-2, in a patient’s bloodstream. Some antibodies simply indicate whether the individual has been previously exposed to either the virus or a vaccine, while others – known as neutralizing antibodies – provide immunity against infection or re-infection. In the case of SARS-CoV-2, neutralizing antibodies work by interfering with the virus’ spike protein, which is the key that the virus uses to enter respiratory system cells by binding to the ACE2 receptors on the cells’ surface.

The new antibody test is a highly sensitive and extremely accurate way of measuring how well a sample of blood serum can prevent the spike protein in its trimeric form – as found on the surface of the SARS-CoV-2 virus – from binding to ACE2 receptors. It completes the diagnostic arsenal in development at EPFL, which also includes the microchip device presented two months ago. Because the new method requires a simple blood test, it can be deployed easily on a large scale. The test results show whether a patient has developed immunity against one or more variants of SARS-CoV-2.

Related Links:
Lausanne University Hospital
EPFL


Gold Supplier
COVID-19 RT-PCR Kit
CoviPath COVID-19 RT-PCR Kit
New
Cooling System
Cryolys Evolution
New
PCR System
Biomark HD
New
Immunoassay Analyzer
AFIAS-1

Print article

Channels

Molecular Diagnostics

view channel
Image: Primary angle closure glaucoma can cause permanent blindness if not treated quickly. A highly sensitive genetic test has been developed (Photo courtesy of Flinders University)

Highly Sensitive Genetic Test for Glaucoma Developed

In open-angle glaucoma, the angle in the eye where the iris meets the cornea is as wide and open as it should be, but the eye’s drainage canals become clogged over time, causing an increase in internal... Read more

Industry

view channel
Illustration

ELITechGroup Acquires Freezing Point Osmometry Provider GONOTEC

ELITechGroup (Puteaux, France) has acquired GONOTEC (Berlin, Germany), thus uniting two osmometry market leaders. The acquisition will also provides the industry with a full range of osmometry solutions... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.